Translating Stem Cell Therapies: From the Lab to Patients 2019

Stem cell research is advancing rapidly, and the FDA anticipates receiving more than 200 new applications for cell and gene therapy products each year beginning in 2020. By 2025, the agency predicts as many as 10-20 new therapies may be approved for clinical use each year. Many discoveries are now in or moving toward therapeutic applications and being tested in early phase clinical trials. Which treatments are holding the most promise? What are the challenges or concerns in translating scientific discoveries to therapeutic applications in patients?

Moderator: Charles Murry, MD, PhD, Univ. Washington, USA
Speakers: David Lebwohl, MD, Semma Therapeutics, USA
Sally Temple, PhD, Neural Stem Cell Institute, USA
Viviane Tabar, MD, Memorial Sloan-Kettering Cancer Center, USA

Видео Translating Stem Cell Therapies: From the Lab to Patients 2019 канала International Society for Stem Cell Research (ISSCR)